Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Regeneron Pharmaceuticals Incorporated

Highlights

A collection of news and information related to Regeneron Pharmaceuticals Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-5 of 5
» View baltimoresun.com items only
    May 8, 2012 |Story| Reuters
  1. U.S. FDA advisers rebuff Regeneron gout drug

    Reuters
    * Advisers vote 11-0 against approval of Arcalyst * Drug meant to prevent gout flares * FDA to make final decision by July 30 WASHINGTON, May 8 (Reuters) - U.S. drug advisers unanimously voted against Regeneron Pharmaceuticals Inc's experimental...

    Tags: Drugs and Medicines, Food and Drug Administration, Genes and Chromosomes

  2. May 4, 2012 |Story| Reuters
  3. FDA staff question studies for Regeneron gout drug

    Reuters
    WASHINGTON, May 4 (Reuters) - U.S. drug reviewers said Regeneron Pharmaceuticals Inc's drug to prevent gout flares worked, but questioned its side effects and whether it did enough to help patients. The Food and Drug Administration staff said the drug,...

    Tags: Food and Drug Administration

  4. May 4, 2012 |Story| Reuters
  5. UPDATE 1-FDA staff question side effects of Regeneron gout drug

    Reuters
    (Adds details on drug, company) WASHINGTON, May 4 (Reuters) - U.S. drug reviewers said Regeneron Pharmaceuticals Inc's drug to prevent gout flares worked, but questioned its side effects and whether it did enough to help patients. The Food and Drug...

    Tags: Drugs and Medicines, Food and Drug Administration, Genes and Chromosomes, Placebo, Immune System

  6. May 4, 2012 |Story| Reuters
  7. UPDATE 2-FDA staff question side effects of Regeneron gout drug

    Reuters
    * Arcalyst meant to prevent gout flares * Staff focus on side effects, limited trial of drug * Regeneron shares down 2.4 pct * Advisory committee to review drug on Tuesday (Adds shares, bullets) By Anna Yukhananov WASHINGTON, May 4 (Reuters) - U.S....

    Tags: Drugs and Medicines, Genes and Chromosomes, Food and Drug Administration, Placebo, Trials

  8. Nov 25, 2011 |Story| South Florida Sun-Sentinel
  9. New drug may mean fewer eye shots for macular disease

    A newly approved drug that doctors began using this week may mean fewer shots in the eyes — and savings —- for patients with the incurable disease macular degeneration.
    A newly approved drug that doctors began using this week may mean fewer shots in the eyes — and savings —- for patients with the incurable disease macular degeneration. Tested for years in South Florida seniors, the drug Eylea (aflibercept)...

    Tags: Drugs and Medicines, Deerfield Beach, Bevacizumab (drug), Ophthalmology, Macular Degeneration

Original site for Regeneron Pharmaceuticals Incorporated topic gallery.